The Claim
In patients with coronary artery disease undergoing percutaneous coronary intervention, baseline high-sensitivity C-reactive protein levels above 3 mg/L are associated with a 4.9% rate of major adverse cardiac and cerebrovascular events within one year, while levels below 2 mg/L are associated with a 2.6% rate of such events.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with coronary artery disease who have higher levels of a blood marker called high-sensitivity C-reactive protein before undergoing heart procedure are more likely to experience a heart attack, stroke, or death within one year than those with lower levels of this marker.
See the scientific wording
In patients with coronary artery disease undergoing percutaneous coronary intervention, baseline high-sensitivity C-reactive protein levels above 3 mg/L are associated with a 4.9% rate of major adverse cardiac and cerebrovascular events within one year, compared to 2.6% in those with levels below 2 mg/L, indicating that systemic inflammation, as measured by hsCRP, correlates with increased risk of death, heart attack, or stroke after the procedure.
High levels of a blood protein called hsCRP signal widespread inflammation in the body, which activates immune cells inside artery walls. These cells break down the protective covering of fatty plaques, making them more likely to rupture. When a plaque ruptures, it triggers blood clotting that can block the artery, causing a heart attack, stroke, or death.
What the research says
1 studyThe study found that heart patients with higher levels of a blood marker called hsCRP (above 3 mg/L) were more likely to have a heart attack, stroke, or die within a year than those with lower levels (below 2 mg/L), which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.